• Anderson, J. C., M. A. Barton, R. A. Gregory, et al.: Antral hormone gastrin. Synthesis of gastrin. Nature 1964, 204, 933934.
  • Bock, M. G., R. M. DiPardo, B. E. Evans, et al.: Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. J. Med. Chem. 1989, 32, 1316.
  • Chambers, M. S. & S. R. Fletcher: CCK-B antagonists in the control of anxiety and gastric acid secretion. Prog. Med. Chem. 2000, 37, 4581.
  • Chang, R. S. L., V. Lotti, J. Monaghan, et al.: A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 1985, 230, 177179.
  • Gregory, H., P. M. Hardy, D. S. Jones, et al.: Antral hormone gastrin. Structure of gastrin. Nature 1964, 204, 931932.
  • Gregory, R. A. & H. J. Tracy: The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 1964, 5, 103117.
  • Gregory, R. A. & H. J. Tracy: Isolation of two ``big gastrins'' from ZollingerEllison tumour tissue. Lancet 1972, 2, 797799.
  • Hughes, J., P. Boden, B. Costall, et al.: Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 67286732.
  • Kalindjian, S. B., M. J. Bodkin, I. M. Buck, et al.: A new class of non-peptidic cholecystokinin-B/gastrin receptor antagonists based on dibenzobicyclo-[2.2.2]octane. J. Med. Chem. 1994, 37, 36713673.
  • Kalindjian, S. B., I. M. Buck, J. R. Cushnir, et al.: Improving the affinity and selectivity of a nonpeptide series of cholecystokinin-B/gastrin receptor antagonists based on the dibenzobicyclo[2.2.2]octane skeleton. J. Med. Chem. 1995, 38, 42944302.
  • Kalindjian, S. B., I. M. Buck, J. M. R. Davies, et al.: Non-peptide cholecystokininB/gastrin receptor antagonists based on bicyclic heteroaromatic skeletons. J. Med. Chem. 1996, 39, 18061815.
  • Kalindjian, S. B., D. J. Dunstone, C. M. R. Low, et al.: Nonpeptide cholecystokinin2 receptor agonists. J. Med. Chem. 2001, 44, 11251133.
  • Low, C. M. R., J. W. Black, S. B. Kalindjian, et al.: Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists. J. Med. Chem. 2000, 43, 35053517.
  • Martinez, J., M. Rodriguez, J. P. Bali & J. Laur: Phenethylamide derivatives of the C-terminal tetrapeptide of gastrin. Int. J. Pept. Prot. Res. 1986, 28, 529535.
  • McDonald, I. M.: CCK2 receptor antagonists. Exp. Opin. Ther. Patents 2001, 11, 445462.
  • Morley, J. S.: Synthesis of human gastrin (1) and the biological properties of analogues. Peptides 1967, 226234.
  • Revel, L., L. Mennuni, O. Letari, et al.: Gastric acid antisecretive activity of CR2945, a new potent gastrin/CCKB receptor antagonist. Gut 1997, 41 (Suppl 3), .
  • Rodriguez, M., P. Dubreuil, J. P. Bali & J. Martinez: Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin. J. Med. Chem. 1987, 30, 758763.
  • Tracy, H. J. & R. A. Gregory: Human gastrin-isolation, structure and synthesis isolation of two gastrins from human antral mucosa. Nature 1964, 204, 935936.
  • Yu, M. J., K. J. Thrasher, J. R. McCowan, et al.: Quinazoline cholecystokinin-B receptor ligands. J. Med. Chem. 1991, 34, 15081511.